Participants were randomly assigned in a 1:1 ratio to receive either semaglutide 50 mg or a placebo once daily for 68 weeks
Administration errors of compounded semaglutide reported to a poison control centercase series
Week 1 During the first week, many people begin noticing: Improved control around food Less desire to snack Reduced emotional eating Fewer cravings for high-calorie foods Week 2 By week two, appetite suppression often becomes more consistent
C57-Bl mice were randomly assigned to a chow diet (N) group, a HFD group, and one of three dosages of oat beta-glucan (high beta-glucan, medium beta-glucan, and low beta-glucan)
48,49 Heart Rate Increase GLP-1RAs are known to cause a modest, dose-dependent increase in resting heart rate
Research indicates tirzepatide-induced weight loss can lead to favorable hormonal changes